Stay updated on KTE-C19 + Atezolizumab in DLBCL Clinical Trial
Sign up to get notified when there's something new on the KTE-C19 + Atezolizumab in DLBCL Clinical Trial page.

Latest updates to the KTE-C19 + Atezolizumab in DLBCL Clinical Trial page
- Check2 days agoChange DetectedThe page now displays that recruitment has ended, and new help sections such as How to Read a Study Record, Common Questions, and How to Join a Study have been added; the Intervention / Treatment label formatting has been updated to Intervention/Treatment, and the revision tag updated from v3.5.5 to v3.6.0.SummaryDifference0.3%

- Check9 days agoChange DetectedThe page’s revision indicator was updated from v3.5.4 to v3.5.5, signaling an updated iteration of the page.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedRevision updated from v3.5.3 to v3.5.4, reflecting a version bump to the page metadata. This is a minor update to the page's revision reference and does not alter visible content.SummaryDifference0.0%

- Check53 days agoChange DetectedThe page now shows an updated site/software revision identifier, changing the revision value from v3.5.2 to v3.5.3.SummaryDifference0.0%

- Check60 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check89 days agoChange DetectedRevision metadata updated: added v3.5.0 and removed v3.4.3.SummaryDifference0.0%

Stay in the know with updates to KTE-C19 + Atezolizumab in DLBCL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KTE-C19 + Atezolizumab in DLBCL Clinical Trial page.